ACKNOWLEDGMENTS
The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.
Funding
This special issue is supported by the American Academy of Addiction Psychiatry (AAAP). Funding for this initiative was made possible (in part) by Providers' Clinical Support System for Opioid Therapies (grant nos. 5H79TI023439 and 1H79TI025595) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the US government.